COMPARISON OF A COSMETIC SERUM AND 4% HYDROQUINONE FOR TREATING MELASMA OVER 84 DAYS

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 23, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

December 22, 2025

Conditions
HealthyMelasma (Facial Melasma)Epidermal Melasma
Interventions
DRUG

Depigmenting Cosmetic Serum (Applied Morning and Evening)

Participants in Group 1 receive a depigmenting cosmetic serum with non-drug actives applied morning and evening, plus a placebo cream without hydroquinone applied in the evening. Group 2 receives a placebo serum (no active depigmenting ingredients) applied morning and evening, and a hydroquinone 4% cream applied in the evening. All participants apply an SPF50+ sunscreen in the morning throughout the 84-day study. The cosmetic serum is the investigational product; hydroquinone serves as the active comparator. Placebo products are visually matched to their respective actives to ensure blinding. The study distinguishes each intervention by active ingredients, timing of application (morning/evening), and role (test vs. reference vs. supportive care). All products are applied topically, and the regimen remains fixed across the study duration.

Trial Locations (1)

73408

RECRUITING

Centre International de Développement Pharmaceutique, Port Louis

All Listed Sponsors
collaborator

CIDP Mauritius

UNKNOWN

lead

Laboratoire Dermatologique ACM

INDUSTRY

NCT07071363 - COMPARISON OF A COSMETIC SERUM AND 4% HYDROQUINONE FOR TREATING MELASMA OVER 84 DAYS | Biotech Hunter | Biotech Hunter